In the published article, there was an error. The molecular weights of “GF9-HFn/Str, HFn, GF9-HFn and GF9-HFn + MMP2” in the original article were wrong. The molecular weights of “GF9-HFn/Str, HFn and GF9-HFn” in the original article were displayed as “36 kD, 33.1 kD and 36 kD”. But the correct size of “GF9-HFn/Str is 40 kD”, the correct size of “HFn is 35 kD” and the correct size of “GF9-HFn is 40 kD”.
In the published article, there was an error in Abstract section.
“The size of GF9-HFn/Str is 36 kD”.
The corrected sentence appears below:
“The size of GF9-HFn/Str is 40 kD”.
In the published article, there was an error in Results section titled The evaluation of ferritin-based codelivery nanoparticle.
“We found that the size of GF9-HFn/Str (36 kD) is bigger than HFn (33.1 kD; Figure 1A)”.
The corrected sentence appears below:
“We found that the size of GF9-HFn/Str (40 kD) is bigger than HFn (35 kD; Figure 1A)”.
In the published article, there was an error in Results section titled GF9 can be released by MMP2.
“Then, SDS-PAGE assessed the protein molecules. Compared with GF9-HFn (36 kD), the cells added MMP2 enzyme separated the band of GF9-HFn + MMP2 (36 kD) into two bands, which are HFn (33.1 kD) and GF9 (2.9 kD) (Figure 2B)”.
The corrected sentence appears below:
“Then, SDS-PAGE assessed the protein molecules. Compared with GF9-HFn (40 kD), the cells added MMP2 enzyme separated the band of GF9-HFn + MMP2 into two bands, which are HFn (35 kD) and GF9 (2.9 kD) (Figure 2B)”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
nanomedicine, GF9, streptomycin, sepsis, gram-negative bacteria-induced
Citation
Wei B and Ma Y (2023) Corrigendum: Synergistic effect of GF9 and streptomycin on relieving gram-negative bacteria-induced sepsis. Front. Bioeng. Biotechnol. 11:1204254. doi: 10.3389/fbioe.2023.1204254
Received
12 April 2023
Accepted
18 May 2023
Published
16 June 2023
Volume
11 - 2023
Edited and reviewed by
Muhammad Wajid Ullah, Jiangsu University, China
Updates
Copyright
© 2023 Wei and Ma.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yingmin Ma, ma.yingmin@163.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.